Linea Busch
About Linea Busch
Linea Busch is a Validation Engineer at Kite Pharma in the Amsterdam area, with expertise in the qualification of production and laboratory equipment. She has a background in molecular and cellular biology research and has held various positions in academia and the pharmaceutical industry.
Work at Kite Pharma
Linea Busch has been employed at Kite Pharma as a Validation Engineer since 2019. In this role, she is responsible for the qualification of production and laboratory equipment, ensuring compliance with industry standards. Her work contributes to the operational efficiency and regulatory compliance of Kite Pharma's facilities in the Amsterdam area, Holland.
Education and Expertise
Linea Busch holds a Master of Science (MSc) in Molecular Biomedicine from the University of Copenhagen, where she studied from 2011 to 2013. She also completed a Bachelor of Science (BSc) in the same field at the same institution from 2008 to 2011. Additionally, she participated in a Summerschool program in Oncology and Cancer Biology at Universiteit Utrecht in 2012 and studied Science at the University of Sydney in 2010. Her academic background supports her expertise in the qualification of production and laboratory equipment.
Background
Linea Busch has a diverse professional background in the life sciences sector. She began her career as a Student Assistant at Novozymes in 2007 and later worked at the Danish Medicines Agency. She has held various positions, including Research Assistant at Rigshospitalet and Validation Scientist at Novo Nordisk. Her experiences span across different roles in both academic and clinical settings, providing her with a solid foundation in molecular and cellular biology research.
Achievements
Throughout her career, Linea Busch has developed strong organizational and interpersonal communication skills, along with analytical and problem-solving abilities. Her experience in project planning and the start-up of new facilities has been instrumental in her roles, particularly during her tenure at Kite Pharma and Novo Nordisk. These skills enhance her contributions to validation processes and compliance in the pharmaceutical industry.